We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

176 hedge funds and large institutions have $72.4M invested in Definium Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $5.21M | Put options by funds: $2.36M

54% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 35

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

1% more funds holding

Funds holding: 174 → 176 (+2)

0.05% less ownership

Funds ownership: 0.87% → 0.82% (-0.05%)

31% less capital invested

Capital invested by funds: $105M → $72.4M (-$32.4M)

Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
54
Reduced
35
Closed
29
Calls
$5.21M
Puts
$2.36M
Net Calls
+$2.85M
Net Calls Change
+$1.65M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$4.69M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.96M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.68M
4
BB
Busey Bank
Illinois
+$918K
5
BlackRock
BlackRock
New York
+$816K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$1.68M
2
MI
MMCAP International
Cayman Islands
-$759K
3
Millennium Management
Millennium Management
New York
-$673K
4
Simplex Trading
Simplex Trading
Illinois
-$362K
5
SC
Shay Capital
New York
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC World Market
101
CIBC World Market
Ontario, Canada
$21K +$351 +11 +1%
BFS
102
Bard Financial Services
Connecticut
$21K +$31.9K +1,000 New
GKWIM
103
Gerber Kawasaki Wealth & Investment Management
California
$21K +$33K +1,035 +103,500%
Osaic Holdings
104
Osaic Holdings
Arizona
$19K -$127K -3,984 -82%
UCFA
105
United Capital Financial Advisors
Texas
$19K -$3.19K -100 -10%
Belvedere Trading
106
Belvedere Trading
Illinois
$18K -$324K -10,149 -89%
FBB
107
Fulton Breakefield Broenniman
Maryland
$18K – – –
SIA
108
Schechter Investment Advisors
Michigan
$18K +$27.7K +867 New
MCM
109
MAI Capital Management
Ohio
$18K +$28.1K +880 New
SSB
110
Sandy Spring Bank
Maryland
$17K – – –
EWA
111
EP Wealth Advisors
California
$17K +$26.3K +825 New
Bank Julius Baer & Co
112
Bank Julius Baer & Co
Switzerland
$17K +$26.7K +837 New
PTP
113
Platform Technology Partners
New York
$16K -$7.98K -250 -25%
IA
114
IFP Advisors
Florida
$16K -$3.19K -100 -12%
American Century Companies
115
American Century Companies
Missouri
$16K – – –
PA
116
Profund Advisors
Maryland
$16K +$3.38K +106 +16%
NP
117
NorthRock Partners
Minnesota
$15K +$926 +29 +4%
BFM
118
Boothbay Fund Management
New York
$15K +$23.5K +736 New
CIC
119
Chase Investment Counsel
Virginia
$14K – – –
FNT
120
First National Trust
Pennsylvania
$14K – – –
TRCT
121
Tower Research Capital (TRC)
New York
$14K +$1.98K +62 +10%
AWM
122
Aries Wealth Management
Maine
$14K +$21.3K +667 New
EDRH
123
Edmond de Rothschild Holding
Switzerland
$14K +$21.3K +667 New
Federated Hermes
124
Federated Hermes
Pennsylvania
$8K -$160 -5 -1%
PCG
125
Private Capital Group
Connecticut
$8K – – –
3 4
5
6 7

DFTX Hedge Fund Activity: Q4 2021 in Review

176 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2021, worth a combined $72.4M — down 31% from $105M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new DFTX positions and 29 closed out — a net gain of 8 holders — while 54 added to existing stakes and 35 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.69M. The largest seller was Goldman Sachs, cutting an estimated $1.68M.

  • 176 institutional investors held Definium Therapeutics (DFTX) as of Q4 2021, up from 174 in Q3 2021.
  • Funds reported $72.4M of Definium Therapeutics stock for Q4 2021, down 31% quarter-over-quarter.
  • 37 funds opened new Definium Therapeutics positions in Q4 2021 and 29 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q4 2021 was Morgan Stanley, an estimated $4.69M added.
  • The largest Definium Therapeutics seller in Q4 2021 was Goldman Sachs, an estimated $1.68M sold.

Based on aggregated 13F filings for Q4 2021.